Bio-Techne beats third-quarter estimates on improving demand for biotech products [Reuters]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Reuters
demand for its cell and gene therapy products and testing and diagnostic devices. On an adjusted basis, the company posted a profit of 48 cents per share, beating analysts' estimates of 45 cents per share, according to LSEG data. "As expected, we experienced subsiding headwinds from de-stocking but also delivered year-over-year growth in a depressed biopharma end market," said CEO Kim Kelderman. The company said in a conference call in February that the soft funding environment continued to impact China, which contributed to 10% of the company's total revenues in the fiscal year 2023, according to latest regulatory filings. However, the company added it expects headwinds to be less severe going forward as inflation and interest rates appear to have stabilized in China. The Minnesota-based company reported third-quarter revenue of $303.4 million, compared with analysts' estimates of $292.2 million. Sales at its largest protein sciences unit were $214.6 million, a fall of 2%
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Water Street Healthcare Partners Appoints Kevin Gould as Executive Advisor [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Corporation (TECH) Declined on Weak Q4 Results [Yahoo! Finance]Yahoo! Finance
- Bio-Techne Third Quarter 2024 Earnings: Beats Expectations [Yahoo! Finance]Yahoo! Finance
- BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024PR Newswire
- BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) [Yahoo! Finance]Yahoo! Finance
TECH
Earnings
- 5/1/24 - Beat
TECH
Sec Filings
- 5/14/24 - Form 144
- 5/6/24 - Form 10-Q
- 5/3/24 - Form 4
- TECH's page on the SEC website